Skip to main content

Pillar 03Standards & Accreditation

ISO 17025 explained — why accreditation matters more than logos

What ISO/IEC 17025 accreditation actually means for a peptide testing laboratory, what it requires the lab to demonstrate, what its scope statement does and does not cover, and how to verify a lab's accreditation independently.

Published 19 May 2026Byline labowned editorialVersion v1.0

The phrase "ISO 17025 accredited" appears on peptide laboratory websites, marketing materials, and the corners of Certificates of Analysis. What it actually means — and what it does not mean — separates labs that have submitted to external assessment of their measurement competence from those who have only claimed to.

This article walks through what ISO/IEC 17025 requires, what the scope of an accreditation covers, how to read an accreditation certificate, and how to verify a laboratory's status independently of what the lab itself says.

What ISO 17025 is

ISO/IEC 17025 is the international standard that specifies the general requirements for the competence of testing and calibration laboratories. The current edition, ISO/IEC 17025:2017, was published jointly by the International Organization for Standardization and the International Electrotechnical Commission. It is the global reference against which laboratories are assessed for technical competence and the operation of a management system.

Two things make ISO 17025 different from many laboratory standards.

First, it is competence-based. Where a quality-management standard like ISO 9001 asks whether the laboratory has a documented process, ISO 17025 asks whether the laboratory's results are technically correct. The requirements cover personnel competence, equipment fitness, validated methods, traceability of measurements to international standards, estimation of measurement uncertainty, and the technical handling of test samples. A laboratory can have an immaculate quality manual and still fail ISO 17025 assessment if its measurements are not accurate.

Second, it is scope-specific. ISO 17025 accreditation is not a blanket statement that "this lab does good work." It applies to specific test methods, specific analytes, specific matrices, and specific measurement ranges. A laboratory accredited for HPLC purity determination of pharmaceutical-grade peptides in lyophilised powder matrix has been assessed for exactly that — not for residual-solvent GC of acetonitrile in plasma, even though it might perform that test routinely.

What the standard requires

ISO 17025:2017 requires the laboratory to demonstrate, to an external accreditation body, several categories of capability:

  • Personnel competence. Documented qualifications, training records, ongoing competency assessment for each analyst on each method they perform.
  • Validated methods. Each method used to produce reported results must be validated against ICH Q2(R2), USP, or equivalent criteria — specificity, linearity, accuracy, precision, detection and quantitation limits, robustness. Validation records must be retained and accessible.
  • Equipment fitness. Instruments must be qualified (installation qualification, operational qualification, performance qualification) and maintained under documented schedules. Calibration of measuring equipment must be traceable to international standards through an unbroken chain.
  • Measurement traceability. Every reported numerical value must, in principle, trace to the SI base units through calibrated references. For HPLC purity, this typically means weighing on calibrated balances (traceable to mass standards), using calibrated volumetric devices (traceable to length standards via density), and operating chromatographs calibrated against certified reference materials.
  • Measurement uncertainty. The laboratory must estimate and report the uncertainty associated with each measurement. A "purity of 99.0%" with no uncertainty estimate is incomplete; "99.0 ± 0.3% with 95% confidence" is the format an accredited laboratory would produce.
  • Quality system. Document control, internal audits, management review, corrective and preventive actions, handling of complaints, control of records. The familiar machinery of a quality management system, but explicitly directed at the technical work rather than at procedural compliance for its own sake.
  • Impartiality and confidentiality. Documented arrangements to prevent commercial or other pressures from compromising results, and to protect customer information.

The accreditation body assesses each of these areas through document review, witnessed testing of actual samples, and interviews with analysts. Reassessment cycles are set by each accreditation body — typically a full reassessment every few years, with surveillance visits in between.

Accreditation bodies and the mutual recognition framework

A laboratory is not accredited by ISO itself. It is accredited by a national accreditation body that has signed the International Laboratory Accreditation Cooperation mutual recognition arrangement. The accreditation body operates against ISO/IEC 17011 — the standard governing accreditation bodies themselves — and is in turn peer-reviewed by other ILAC signatories.

In practice, this means a laboratory might be accredited by:

  • The American Association for Laboratory Accreditation (A2LA) in the United States
  • The National Association of Testing Authorities (NATA) in Australia
  • The United Kingdom Accreditation Service (UKAS) in the UK
  • Deutsche Akkreditierungsstelle (DAkkS) in Germany
  • The Czech Accreditation Institute (ČIA) in the Czech Republic

…and so on across roughly 100 national accreditation bodies. Through the ILAC mutual recognition arrangement, a result issued by a laboratory accredited by any signatory is recognised as equivalent in any other signatory's jurisdiction — at least in technical terms; regulatory acceptance is a separate matter.

The accreditation body issues a certificate that lists the laboratory's accredited scope. This certificate, together with the scope schedule, is the document that matters. "ISO 17025 accredited" on a website tells you the laboratory claims accreditation; the certificate and scope schedule tell you what they are actually accredited for.

Reading the scope statement

The scope schedule is where accreditation becomes operationally meaningful. A representative entry on a peptide testing laboratory's scope might read:

Test method: Reversed-phase HPLC for purity determination of synthetic peptides Standard: USP General Chapter <621> (Chromatography) Analyte range: Synthetic peptides 5–50 amino acids in length, molecular weight 500–6000 Da Matrix: Lyophilised powder Measurement range: Purity 90–100% area Uncertainty: ±0.5% area at 95% confidence

This single entry is far more informative than any logo. It tells you the laboratory has been assessed competent to determine purity by reversed-phase HPLC, on lyophilised synthetic peptides in a defined size range, over a defined purity range, with a stated uncertainty. A peptide outside that range — say a 80-residue peptide, or a peptide-protein conjugate — is outside the scope. The laboratory might still test it, but the result is not covered by the accreditation.

The same lab might also have scope entries for mass spectrometry identity confirmation, for endotoxin testing by LAL, for residual solvents by GC, and so on. Each scope entry stands alone. Buyers should match the test they need against the scope schedule, not against the bare claim of accreditation.

How to verify accreditation independently

A claim of ISO 17025 accreditation is verifiable, and the verification process is straightforward. Two routes:

  1. The accreditation body's public registry. Every reputable accreditation body publishes a searchable list of accredited laboratories. NATA, UKAS, A2LA, DAkkS, and others maintain free public databases where a laboratory's accreditation status, accreditation number, and current scope schedule can be looked up.
  2. The laboratory's certificate. A laboratory whose accreditation is current should be willing to provide the current certificate (a one- or two-page document) and the current scope schedule (typically several pages listing all accredited methods). Both documents carry the accreditation body's letterhead and a unique accreditation number.

If a laboratory refuses to provide its certificate, or its claimed accreditation number does not appear in the accreditation body's registry, the claim is at best out of date and at worst false. The mutual recognition arrangement is open and transparent precisely so that buyers can verify without relying on the laboratory's marketing.

What ISO 17025 is not

Several common misunderstandings deserve correction.

ISO 17025 is not GMP. Good Manufacturing Practice (GMP) is a separate regulatory framework, principally for the manufacture of medicinal products. A laboratory may be ISO 17025 accredited without being GMP compliant, and vice versa. For research peptides — which are not medicinal products in most jurisdictions — ISO 17025 is the relevant accreditation; GMP is generally not.

ISO 17025 is not ISO 9001. ISO 9001 is a general quality management standard. ISO 17025 incorporates a subset of ISO 9001's management requirements plus the technical competence requirements unique to laboratories. ISO 9001 certification on a laboratory is reassurance about management practice; ISO 17025 accreditation is reassurance about measurement.

ISO 17025 does not certify products. It accredits the laboratory's ability to test. A peptide is not "ISO 17025 certified" — only the laboratory that tested it can be. A vendor claiming their peptides are ISO-certified is misusing the terminology.

ISO 17025 is not a guarantee of accuracy on a specific sample. Accreditation says the laboratory has demonstrated competence on the methods within its scope. A specific test on a specific sample can still go wrong — instruments drift, samples degrade, analysts err. The accreditation gives you grounds to trust the laboratory's quality system to catch and correct such errors; it does not promise that no error will ever occur.

Why it matters for peptide buyers

For a research peptide buyer, the practical implications:

  • A non-accredited laboratory may still produce accurate results. Accreditation is a meaningful signal but not a binary gate. A lab without accreditation may have excellent technical practice; a lab with accreditation may operate at the minimum of what the standard requires. Accreditation is evidence, not proof.
  • An accredited result with no uncertainty estimate is internally inconsistent. ISO 17025 requires uncertainty reporting. A COA on accredited-laboratory letterhead that omits uncertainty is either operating outside its scope, has dropped a requirement, or is for a parameter that does not normally carry uncertainty.
  • The scope statement is the document you want. Not the certificate, not the website badge. The scope schedule tells you what the accreditation actually covers. Without it, you cannot tell whether the test you need is in scope.

Regulatory frameworks in Australia (administered by the Therapeutic Goods Administration), the European Union, and the United States routinely require ISO 17025 accreditation for laboratories whose results support regulatory submissions. The accreditation infrastructure exists to make laboratory measurements internationally portable and independently verifiable — exactly the properties a peptide buyer trying to evaluate a result also benefits from, even when the underlying transaction is not regulated.

Further reading

The mechanics of the third-party testing process — how laboratories like those discussed here actually receive samples and produce reports — are covered in the third-party peptide testing landscape article. The chromatographic methods that an accredited laboratory uses to measure peptide purity are explained in HPLC for peptides, and the document those measurements end up on is dissected in how to read a peptide Certificate of Analysis.

For regulatory context, the Therapeutic Goods Administration publishes the framework that governs laboratory testing in Australian healthcare contexts; the broader policy and public-health context around peptide regulation is covered at Coalition for Better Health. The natural-medicines regulatory landscape, where peptide research often intersects with traditional therapeutic frameworks, is at Naturopathic Science.

For the standards themselves, the primary references are ISO/IEC 17025:2017, the International Laboratory Accreditation Cooperation for the mutual recognition framework, and the United States Pharmacopeia for the general chapters that accredited laboratories implement.